UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000002632
Receipt number R000003207
Scientific Title Clinical pharmacology study of anti-estrogen based on pharmacogenomics and pharmacokinetics for hormone-sensitive breast cancer patients (JBCRG-15)
Date of disclosure of the study information 2009/11/01
Last modified on 2021/08/13 16:09:25

No. Disposal Last modified on Item of update
1 Insert 2009/10/15 18:41:20
2 Update 2010/01/20 11:15:44 UMIN ID1
3 Update 2010/09/22 15:49:27 Public title
Public title
4 Update 2010/09/22 15:50:16 Recruitment status
5 Update 2010/10/15 12:30:30 Address
Address
Address
Name of person sending information
Organization
Division name
Division name
Address
Address
6 Update 2011/11/28 15:30:27 Institute
Institute
Organization
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
7 Update 2011/11/28 15:48:16 Last follow-up date
8 Update 2012/05/15 16:50:46 Institutions
9 Update 2013/06/17 16:31:23 Acronym
Acronym
10 Update 2013/06/17 16:32:19 Institute
Organization
11 Update 2014/04/15 10:28:03 Division name
TEL
Email
Last name of contact person
Last name of contact person
Division name
TEL
Email
Division name
TEL
12 Update 2014/04/15 10:28:27 Recruitment status
13 Update 2016/07/08 15:08:11 Name of primary person or sponsor
Organization
14 Update 2018/08/23 17:35:58 Acronym
15 Update 2019/09/05 13:51:16 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
16 Update 2019/09/05 14:04:24 Recruitment status
Date of IRB
Anticipated trial start date
Last follow-up date
17 Update 2019/09/05 14:07:19 Number of participants that the trial has enrolled
Results Delayed
Results Delay Reason
Results Delay Reason
18 Update 2021/08/06 11:21:19 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Results Delayed
Results Delay Reason
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
19 Update 2021/08/13 16:09:25 Participant flow
Participant flow